issues with semaglutide Ozempic (semaglutide) is a GLP-1 receptor agonist used for type 2 diabetes (and sometimes weight loss). Its side effects range from common GI symptoms to rare but serious risks. ⸻ 🟡 Common Ozempic (semaglutide) and vaginal health

Semaglutide activates only GLP-1 receptors (not GIP), which produces slightly less dramatic weight loss on average but may come with fewer side effects for certain individuals

Patients using Wegovy often report significant reductions in body weight, with clinical trials showing an average weight loss of around 15% of their initial body weight

and four groups of patients who were still taking trial product without rescue medication, defined by randomized treatment arm

Weight Loss Results: What the Data Actually Shows Lets be specific about what better means in clinical trials

Moreover, GLP-1-T has demonstrated efficacy in lowering liver fat